Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)-Reference-Cited by-同舟云学术

Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)

Published:2020-04 Issue:4 Volume:22 Page:681-685
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Pal Tuya,Agnese Doreen,Daly Mary,La Spada Albert,Litton Jennifer,Wick Myra,Klugman Susan,Esplin Edward D.,Jarvik Gail P.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/s41436-019-0712-x.pdf

Reference33 articles.

1. American Cancer Society. Cancer facts & figures 2019. Atlanta, GA: 2019.

2. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients;Kurian;J Clin Oncol,2019

3. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation;Robson;N Engl J Med,2017

4. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation;Litton;N Engl J Med,2018

5. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers;Drohan;Ann Surg Oncol,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort;Cancers;2024-09-03

2. Observational Study of Men and Women with Breast Cancer in Terms of Overall Survival;Cancers;2024-09-01

3. Genome-first evaluation with exome sequence and clinical data uncovers underdiagnosed genetic disorders in a large healthcare system;Cell Reports Medicine;2024-05

4. Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation;Cold Spring Harbor Perspectives in Medicine;2023-12-27

5. Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria;Cancers;2023-05-06